SYRA HEALTH CORP. Deferred Tax Assets, Valuation Allowance
SYRA HEALTH CORP. (SYRA) had Deferred Tax Assets, Valuation Allowance of $2.09 million as of 2025-12-31, per its S-1 filed 2026-09-14.
Financial Statements › Notes › Income Taxes › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2026-09-14
- 2025-12-31: Deferred Tax Assets, Valuation Allowance $2.09M.
- 2024-12-31: Deferred Tax Assets, Valuation Allowance $1.90M.
- 2023-12-31: Deferred Tax Assets, Valuation Allowance $1.03M.
- 2022-12-31: Deferred Tax Assets, Valuation Allowance $332.40K.
| Period end | Deferred Tax Assets, Valuation Allowance |
|---|---|
| 2025-12-31 | $2.09M S-1 · filed 2026-09-14 |
| 2024-12-31 | $1.90M S-1 · filed 2026-09-14 |
| 2023-12-31 | $1.03M 10-K · filed 2025-03-11 |
| 2022-12-31 | $332.40K 10-K · filed 2024-03-25 |